Abbisko Therapeutics Co, Ltd

Related records

Trials (39)

• A Clinical Trial to Evaluate a High-Fat Meal and Omeprazole Enteric-coated Tablets on ASBK021
• A Clinical Trial to Evaluate the Effect of Itraconazole and Rifampicin on ABSK021
• A Clinical Trial to Evaluate the Relative Bioavailability of New and Old ABSK-011 Capsules
• A Early Study of ABSK131 in Patients With Advanced/Metastatic Solid Tumors
• A Mass Balance Study of [14C]ABSK011
• A Mass Balance Study of [14C]ABSK021
• A Phase 1b/2 Clinical Study to Evaluate the Safety and Tolerability and Efficacy of AZD4547
• A Phase 2 Clinical Study of ABSK061 and ABSK043
• A Phase 2 Clinical Study of Combination Therapy With ABSK043 and Firmonertinib
• A Phase 2 Clinical Study of Combination Therapy With ABSK043 and Glecirasib
• A Phase 2 Study of ABSK021 in Patients With Advanced Pancreatic Cancer
• A Phase 2 Study of ABSK043 Combined With Osimertinib
• A Phase 2, Open-Label Study of ABSK-011 Combined Atezolizumab or SOC in HCC Patients
• A Phase I Study of ABSK211 in Participants With Advanced Solid Tumors With KRAS Alteration
• A Phase I/II Study of ABSK141 in Patients With Advanced Solid Tumors ( ABSK141-101 )
• A Phase II Study Evaluating the Efficacy and Safety of ABSK021 (Pimicotinib)) in the Treatment of cGvHD Chronic Graft Versus Host Disease (cGvHD)
• A Prospective Study to Evaluate the Safety and Efficacy of the Combination Therapy of Irpagratinib, Atezolizumab, and Bevacizumab in Patients With Hepatocellular Carcinoma
• A Study in Children With Achondroplasia
• A Study of ABSK061 to Assess Safety, Tolerability, Pharmacokinetics, and Efficacy in Children With Achondroplasia
• A Study to Assess Safety, Tolerability, and Pharmacokinetics of ABSK043 in Patients With Advanced Solid Tumor